[Federal Register: February 4, 2008 (Volume 73, Number 23)]
[Notices]               
[Page 6518]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04fe08-55]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Pulmonary-Allergy Drug Advisory Committee; Cancellation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The meeting of the Pulmonary-Allergy Drugs Advisory Committee 
scheduled for February 20, 2008, is cancelled. This meeting was 
announced in the Federal Register of December 21, 2007 (72 FR 72737).

FOR FURTHER INFORMATION CONTACT: Teresa A. Watkins, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5630 
Fishers Lane (for express delivery, rm. 1093), Rockville, MD 20857, 
301-827-7001, FAX: 301-827-6776, e-mail: Teresa.Watkins@fda.hhs.gov, or 
FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 
in the Washington, DC area), code 3014512545. Please call the 
Information Line for up-to-date information on this meeting.

    Dated: January 29, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E8-1959 Filed 2-1-08; 8:45 am]

BILLING CODE 4160-01-S